BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Sponsor: AdventHealth Translational Research Institute
A PHASE1 clinical study on Cardiovascular Disease and Diabetes, this trial is completed. The trial is conducted by AdventHealth Translational Research Institute and has accumulated 7 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AdventHealth Translational Research Institute
- Sanford-Burnham Medical Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .